Isolation and analysis of the drug resistance of the flavobacterium and its production of beta-lactamases / 中华烧伤杂志
Chinese Journal of Burns
;
(6): 14-16, 2004.
Article
in Chinese
| WPRIM
| ID: wpr-352245
ABSTRACT
<p><b>OBJECTIVE</b>To investigate the drug resistance of flavobacterium and its ability to produce BLA (beta-lactamases) and ESBLs (Extended-spectrum beta-lactamases).</p><p><b>METHODS</b>The production of BLA and ESBLs from 6 clinical isolated flavobacterium strains was determined by nitrocefin disc test and double-disc synergy method, respectively. The antibiotic susceptibilities of the strains were determined by Kirby-Bauer disc diffusion test and the agar dilution method and the MIC was assessed.</p><p><b>RESULTS</b>All the six flavobacteria were BLA-producing strains and more than 80% of them were ESBLs-producing, and they were highly resistant to beta-lactamase antibiotics (MIC 32 - 256 mg/L), but susceptible to fluoroquinolones and cephalosporin with beta-lactamase inhibitors (MIC 0.125 - 8 mg/L).</p><p><b>CONCLUSION</b>Most of the flavobacteria in nosocomial infections were beta-lactamase-producing and were highly resistant to beta-lactamase antibiotics. Fluoroquinolones and beta-lactamase antibiotics with lactamase inhibitors should be the first choice for the management of infection caused by flavobacterium.</p>
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Pharmacology
/
Ribosomal Proteins
/
Flavobacterium
/
Microbial Sensitivity Tests
/
Drug Resistance, Bacterial
/
Membrane Proteins
/
Metabolism
/
Anti-Bacterial Agents
Limits:
Humans
Language:
Chinese
Journal:
Chinese Journal of Burns
Year:
2004
Type:
Article
Similar
MEDLINE
...
LILACS
LIS